Condition
NSTEMI - Non-ST Segment Elevation MI clinical trials and research
As of November 12, 2026, Find a Trial lists 7 NSTEMI - Non-ST Segment Elevation MI clinical trials that are recruiting, at sites in 8 countries (most in Belgium (1), Netherlands (1), Canada (1)). By phase: Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 8Countries
Newest NSTEMI - Non-ST Segment Elevation MI clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SirPlux Duo dual-API drug-coated balloon to treat new and in‑stent coronary blockages | — | Barcelona and 2 other locations | Recruiting | Jan 27, 2026 |
| Aspirin-free ticagrelor treatment for heart attack patients managed without revascularization | Phase 3 | Montreal, Quebec | Recruiting | Dec 2, 2025 |
| Targeted look at residual inflammation after a heart attack | — | Tirana | Recruiting | Jun 18, 2025 |
| Eating and drinking before urgent heart catheterization | — | Tampa, Florida | Recruiting | May 30, 2025 |
| Using machine learning to improve early diagnosis of acute cardiovascular conditions | — | Basel | Recruiting | Apr 15, 2025 |
| Using AI to predict acute coronary syndrome from white blood cell data | — | Graz, Styria / Steiermark | Recruiting | Apr 25, 2024 |
| Optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI | Phase 4 | Aalst and 19 other locations | Recruiting | Jun 18, 2020 |
All recruiting trials (7)
-
SirPlux Duo dual-API drug-coated balloon to treat new and in‑stent coronary blockages
This study tests the SirPlux Duo drug‑coated balloon in adults with symptomatic coronary artery disease who have either new (de novo) small vessel blockages or in‑stent restenosis to see if it is safe and works well.
-
Aspirin-free ticagrelor treatment for heart attack patients managed without revascularization
This trial will test whether taking ticagrelor alone (no aspirin) lowers bleeding without increasing heart problems in adults who had a heart attack and were treated medically without revascularization.
-
Targeted look at residual inflammation after a heart attack
This project will test whether the neutrophil-to-lymphocyte ratio (NLR) from the first routine blood draw can help predict risk of death in adults (18–85) after an acute coronary syndrome treated with PCI.
-
Eating and drinking before urgent heart catheterization
This trial will try whether letting adults with worsening angina or low-risk NSTEMI eat and drink before an urgent inpatient cardiac catheterization improves comfort without raising the chance of complications.
-
Using machine learning to improve early diagnosis of acute cardiovascular conditions
This study is testing a new tool that uses advanced computer technology to help doctors quickly and accurately diagnose serious heart problems in patients who come to the emergency room with chest pain or trouble breathing.
-
Using AI to predict acute coronary syndrome from white blood cell data
This study is testing if artificial intelligence can predict acute coronary syndrome by looking at white blood cell data in adults, comparing it to standard blood tests.
-
Optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI
This study is testing whether a new blood-thinning treatment for patients with atrial fibrillation undergoing heart procedures is safer and just as effective as the traditional approach that includes more medications.
Related topics
Quick answers
How many NSTEMI - Non-ST Segment Elevation MI clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Belgium (1 trial), Netherlands (1 trial), Canada (1 trial), United States (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.